华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301207 华兰疫苗

已收盘 12-24 15:00:00

{"stockData":{"symbol":"301207","market":"SZ","secType":"STK","nameCN":"华兰疫苗","latestPrice":19.3,"timestamp":1766559834000,"preClose":19,"halted":0,"volume":4985918,"delay":0,"changeRate":0.0158,"floatShares":601000000,"shares":601000000,"eps":0.1173,"marketStatus":"已收盘","change":0.3,"latestTime":"12-24 15:00:00","open":19.03,"high":19.37,"low":18.95,"amount":95712600,"amplitude":0.0221,"askPrice":19.3,"askSize":512,"bidPrice":19.29,"bidSize":113,"shortable":0,"etf":0,"ttmEps":0.1173,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766626200000},"marketStatusCode":5,"adr":0,"adjPreClose":19,"symbolType":"stock","openAndCloseTimeList":[[1766539800000,1766547000000],[1766552400000,1766559600000]],"highLimit":20.9,"lowLimit":17.1,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":601027500,"isCdr":false,"pbRate":2.01,"roa":"--","peRate":164.535379,"roe":"2.2%","epsLYR":0.3436,"committee":0.15347,"marketValue":11600000000,"turnoverRate":0.0083,"status":0,"floatMarketCap":11593000000},"requestUrl":"/m/hq/s/301207","defaultTab":"news","newsList":[{"id":"2590583523","title":"华兰疫苗：流感疫苗批签发批次数量位居国内前列","url":"https://stock-news.laohu8.com/highlight/detail?id=2590583523","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590583523?lang=zh_cn&edition=full","pubTime":"2025-12-12 09:06","pubTimestamp":1765501571,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问董秘公司在流感疫苗市场中处于什么地位？华兰疫苗回复：尊敬的投资者您好，公司在流感疫苗生产和销售领域占据领先地位，具备年产一亿剂四价流感疫苗的产能，根据中国食品药品检定研究院的公开数据显示，截至目前公司已签发流感疫苗批次为55批，批签发批次数量位居国内前列。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200005219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2586786209","title":"华兰疫苗：截至目前已签发流感疫苗55批","url":"https://stock-news.laohu8.com/highlight/detail?id=2586786209","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586786209?lang=zh_cn&edition=full","pubTime":"2025-11-28 15:21","pubTimestamp":1764314481,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)11月28日在投资者关系平台上答复投资者关心的问题。投资者提问：金迪克今年共批下来11批疫苗，贵司批签了多少支流感疫苗？有一千万支吗？华兰疫苗回复：尊敬的投资者您好，根据中国食品药品检定研究院的公开数据显示，截至目前已签发流感疫苗批次为55批，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800016527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2584564965","title":"华兰疫苗跌5.4% 2022年上市见顶募22.76亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584564965","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584564965?lang=zh_cn&edition=full","pubTime":"2025-11-17 17:49","pubTimestamp":1763372978,"startTime":"0","endTime":"0","summary":"中国经济网北京11月17日讯 华兰疫苗 今日收报24.01元，跌幅5.40%。　　华兰疫苗于2022年2月18日在深交所创业板上市，公开发行的股票数量为4001.00万股，发行价格为56.88元/股，保荐机构为华泰联合证券有限责任公司，保荐代表人为贾鹏、刘晓宁。　　华兰疫苗首次公开发行股票募集资金总额为22.76亿元，扣除含税发行费用3156.57万元，实际募集资金净额为22.44亿元。　　2023年5月30日，华兰疫苗发布2022年年度权益分派实施公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20251117/31802081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301207","BK0239"],"gpt_icon":0},{"id":"2579698196","title":"华兰疫苗：流感疫苗批签发批次数量居国内前列","url":"https://stock-news.laohu8.com/highlight/detail?id=2579698196","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579698196?lang=zh_cn&edition=full","pubTime":"2025-10-30 15:27","pubTimestamp":1761809232,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗10月30日在投资者关系平台上答复投资者关心的问题。目前公司在研产品包括吸附无细胞百（三组分）白破联合疫苗、冻干b型流感嗜血杆菌结合疫苗等。公司将持续推进疫苗研发工作，丰富产品管线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000023446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2579713509","title":"华兰疫苗(301207.SZ)发布前三季度业绩，归母净利润1.32亿元，下降50.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579713509","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579713509?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:42","pubTimestamp":1761734550,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰疫苗(301207.SZ)发布2025年三季度报告，该公司前三季度营业收入为8.06亿元，同比减少15.81%。归属于上市公司股东的净利润为1.32亿元，同比减少50.51%。归属于上市公司股东的扣除非经常性损益的净利润为8625.57万元，同比减少56.02%。基本每股收益为0.2224元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362090.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"华兰疫苗(301207.SZ)发布前三季度业绩，归母净利润1.32亿元，下降50.51%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301207"],"gpt_icon":0},{"id":"2576591520","title":"华兰疫苗（301207）披露2025年半年度权益分派实施公告，10月17日股价上涨9.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576591520","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576591520?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:27","pubTimestamp":1760711233,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，华兰疫苗报收于19.49元，较前一交易日上涨9.8%，最新总市值为117.14亿元。近日，华兰生物疫苗股份有限公司发布2025年半年度权益分派实施公告。根据公告，公司2025年半年度权益分派方案已获股东会审议通过，以总股本601,027,500股剔除回购股份6,027,467股后为基数，向全体股东每10股派6.000000元现金（含税），合计派发现金红利357,000,019.80元。股权登记日为2025年10月24日，除权除息日为2025年10月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2574597019","title":"股市必读：华兰疫苗(301207)股东户数1.7万户，较上期减少5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574597019","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574597019?lang=zh_cn&edition=full","pubTime":"2025-10-09 05:00","pubTimestamp":1759957239,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘，华兰疫苗报收于17.28元，上涨0.0%，换手率0.26%，成交量1.59万手，成交额2743.1万元。当日关注点来自交易信息汇总：9月30日主力资金净流入115.73万元，占总成交额4.22%。来自股本股东变化：截至2025年9月20日，华兰疫苗股东户数为1.7万户，较此前减少5.56%，户均持股上升至3.54万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900001393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"gpt_icon":0},{"id":"2571367703","title":"华兰疫苗：华兰疫苗是华兰生物的控股子公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2571367703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571367703?lang=zh_cn&edition=full","pubTime":"2025-09-30 08:48","pubTimestamp":1759193297,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗(301207)09月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司与华兰生物有什么关系？华兰疫苗回复：尊敬的投资者您好，华兰疫苗是华兰生物的控股子公司，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000006662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239","BK0185","BK0028","BK0077","BK0197","BK0188","BK0046","002007"],"gpt_icon":0},{"id":"2568449701","title":"华兰疫苗（301207）披露2025年半年度跟踪报告，9月17日股价下跌1.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568449701","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568449701?lang=zh_cn&edition=full","pubTime":"2025-09-17 23:08","pubTimestamp":1758121701,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，华兰疫苗报收于18.06元，较前一交易日下跌1.26%，最新总市值为108.55亿元。近日，华泰联合证券有限责任公司发布了关于华兰生物疫苗股份有限公司2025年半年度跟踪报告。公告显示，报告期内，保荐人及时审阅了公司的信息披露文件，督导公司建立健全并有效执行各项规章制度，募集资金专户每月查询一次，项目进展与披露一致。报告期内，保荐人及公司未被监管机构采取监管措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"gpt_icon":0},{"id":"2564369415","title":"华兰疫苗(301207)8月10日股东户数1.8万户，较上期减少5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564369415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564369415?lang=zh_cn&edition=full","pubTime":"2025-09-03 17:19","pubTimestamp":1756891193,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华兰疫苗披露，截至2025年8月10日公司股东户数为1.8万户，较7月31日减少1000.0户，减幅为5.26%。在生物制品行业个股中，华兰疫苗股东户数低于行业平均水平，截至8月10日，生物制品行业平均股东户数为3.41万户。从股价来看，2025年7月31日至2025年8月10日，华兰疫苗区间跌幅为3.06%，在此期间股东户数减少1000.0户，减幅为5.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090300028275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207","BK0239"],"gpt_icon":0},{"id":"2562504721","title":"图解华兰疫苗中报：第二季度单季净利润同比增长10.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562504721","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562504721?lang=zh_cn&edition=full","pubTime":"2025-08-28 01:58","pubTimestamp":1756317523,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗2025年中报显示，公司主营收入5996.18万元，同比上升68.77%；归母净利润2079.72万元，同比下降17.71%；扣非净利润-1278.49万元，同比上升40.04%；其中2025年第二季度，公司单季度主营收入3567.92万元，同比上升2631.4%；单季度归母净利润-1197.99万元，同比上升10.03%；单季度扣非净利润-2820.06万元，同比上升20.51%；负债率14.38%，投资收益3906.7万元，财务费用-9.45万元，毛利率75.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800001640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301207"],"gpt_icon":0},{"id":"2560786329","title":"467.18亿元市值限售股今日解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2560786329","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560786329?lang=zh_cn&edition=full","pubTime":"2025-08-18 07:42","pubTimestamp":1755474156,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0054","301611","301207","000591","BK0271","BK0132","BK0214","688728","BK0229","BK0239","SGXZ49509284.SGD","SGXZ81163826.USD","688267"],"gpt_icon":0},{"id":"2559708736","title":"华兰疫苗(301207.SZ)：冻干b型流感嗜血杆菌结合疫苗获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2559708736","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559708736?lang=zh_cn&edition=full","pubTime":"2025-08-13 15:56","pubTimestamp":1755071799,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰疫苗(301207.SZ)发布公告，公司于近日收到国家药品监督管理局核准签发的关于冻干b型流感嗜血杆菌结合疫苗(以下简称“Hib疫苗”)的《药物临床试验批准通知书》。经审查，Hib疫苗符合药品注册的有关要求，同意开展预防由b型流感嗜血杆菌引起的侵袭性感染(包括脑膜炎、肺炎、败血症、蜂窝织炎、关节炎、会厌炎等)的临床试验。“冻干Hib疫苗”的获批是公司产品研发战略布局阶段性的成功，不仅丰富公司产品布局，也是实现公司研发多联多价产品的重要一步，既有利于巩固公司在国内二类疫苗领域的行业地位，又有利于公司疫苗业务的可持续发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301207","BK0239","159646"],"gpt_icon":0},{"id":"2559708196","title":"华兰疫苗：冻干b型流感嗜血杆菌结合疫苗获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2559708196","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559708196?lang=zh_cn&edition=full","pubTime":"2025-08-13 15:45","pubTimestamp":1755071136,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159646","301207","BK0239"],"gpt_icon":0},{"id":"2558557665","title":"华兰疫苗股价微跌0.22% 生物制品板块企业受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2558557665","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558557665?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:18","pubTimestamp":1754669909,"startTime":"0","endTime":"0","summary":"华兰疫苗8月8日报收18.40元，较前一交易日下跌0.04元，成交量为37743手，成交额达0.70亿元。该股当日振幅为2.33%，盘中最高触及18.64元，最低探至18.21元。华兰疫苗是一家专注于生物制品研发生产的医药企业，主要产品包括流感疫苗等预防用生物制品。公司总市值110.59亿元，流通市值26.06亿元。从资金流向来看，华兰疫苗8月8日主力资金净流出316.22万元，近五日累计净流出5106.51万元。风险提示：股市有风险，投资需谨慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/09001852315020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2556604658","title":"华兰疫苗：公司采用以销定产方式制定生产计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2556604658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556604658?lang=zh_cn&edition=full","pubTime":"2025-08-01 15:54","pubTimestamp":1754034864,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰疫苗08月01日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080100024105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2550524767","title":"华兰疫苗股价上涨1.01% 公司完成董事会调整及章程修订","url":"https://stock-news.laohu8.com/highlight/detail?id=2550524767","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550524767?lang=zh_cn&edition=full","pubTime":"2025-07-09 00:50","pubTimestamp":1751993437,"startTime":"0","endTime":"0","summary":"华兰疫苗7月8日股价报收16.96元，较前一交易日上涨1.01%。当日成交量为16622手，成交金额达0.28亿元。华兰疫苗属于生物制品行业，主营业务为人用疫苗的研发、生产和销售。公司主要产品包括流感病毒裂解疫苗、四价流感病毒裂解疫苗等。7月8日公司发布公告称，非独立董事潘若文因工作调整辞任，随后被选举为职工代表董事。同日召开的临时股东大会审议通过了修订公司章程及其附件的议案。7月8日主力资金净流入161.76万元，占流通市值的0.07%。风险提示：投资有风险，入市需谨慎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/09005051571293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","301207"],"gpt_icon":0},{"id":"2544389879","title":"【疫苗股震荡拉升 沃森生物涨超10%】疫苗概念股盘中拉升，沃森生物、东富龙涨超10%，塞力医疗涨停，智飞生物、昭衍新药、康泰生物、华北制药涨超5%，冠昊生物、华兰疫苗等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544389879","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544389879?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:55","pubTimestamp":1750125343,"startTime":"0","endTime":"0","summary":"疫苗概念股盘中拉升，沃森生物、东富龙涨超10%，塞力医疗涨停，智飞生物、昭衍新药、康泰生物、华北制药涨超5%，冠昊生物、华兰疫苗等跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17095551106267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK0251","BK0086","300601","BK0046","300122","BK0070","BK0239","BK0196","BK0201","LU2148510915.USD","LU2580892862.HKD","300171","300238","301207","BK0042","300142","BK0216","BK0028","600812","LU1328615791.USD","06127","LU1064130708.USD","LU2580892789.USD","LU1064131003.USD","BK0188","BK0250","159646","603127","BK1576","BK0191","BK0077","603716"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766561349101,"stockEarnings":[{"period":"1week","weight":-0.0166},{"period":"1month","weight":-0.1059},{"period":"3month","weight":0.1229},{"period":"6month","weight":0.2},{"period":"1year","weight":0.0951},{"period":"ytd","weight":0.1308}],"compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1367},{"period":"1year","weight":0.1697},{"period":"ytd","weight":0.1695}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物疫苗股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"23000人(较上一季度减少4.17%)","perCapita":"26115股","listingDate":"2022-02-18","address":"河南省新乡市红旗区华兰大道甲1号附1号","registeredCapital":"60102万元","survey":"　　华兰生物疫苗股份有限公司的主营业务是人用疫苗研发、生产、销售。公司的主要产品是流感疫苗。","listedPrice":56.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰疫苗,301207,华兰疫苗股票,华兰疫苗股票老虎,华兰疫苗股票老虎国际,华兰疫苗行情,华兰疫苗股票行情,华兰疫苗股价,华兰疫苗股市,华兰疫苗股票价格,华兰疫苗股票交易,华兰疫苗股票购买,华兰疫苗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰疫苗(301207)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰疫苗(301207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}